A study of microsatellite instability of upper urinary tract transitional cell carcinoma

Korean Journal of Urology

Volumn 47, Issue 12, 2006, Pages 1269-1277

  Kang, Taek Won ^a   Lee, Jae Gue ^a   Jung, Seung Il ^a   Choi, Yoo Duk ^a   Choi, Chan ^a   Kwon, Dong Deuk ^a   Park, Kwangsung ^a   Ryu, Soo Bang ^a   Park, Yang Il ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Cancer of urinary tract; Gene expression; Transition cell carcinoma

Indexed keywords

DNA; KI 67 ANTIGEN; PROTEIN MLH1; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; UNIVARIATE ANALYSIS; URETER CARCINOMA; URINARY TRACT CARCINOMA;

EID: 33847647073     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.12.1269     Document Type: Article

References (27)

1. Bishop JM. Molecular themes in oncogenesis. Cell 1991;64: 235-48
2. Sidransky D, Messing E. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 1992;19:629-39
3. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9
4. Chu EH, Boehnke M, Hanash SM, Kuick RD, Lamb BJ, Neel JV, et al. Estimation of mutation rates based on the analysis of polypeptide constituents of cultured human lymphoblastoid cells. Genetics 1988;119:693-703
5. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-63
6. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993;53:5853-5
7. Matsumura Y, Tarin D. DNA fingerprinting survey of various human tumors and their metastases. Cancer Res 1992;52: 2174-9
8. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594-601
9. Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, editors. Campbell's urology. 8th ed. Philadelphia: Saunders; 2002;2732-84
10. Tawfiek ER, Bagley DH. Upper-tract transitional cell carcinoma. Urology 1997;50:321-9
11. Shinohara M, Okazawa A, Suzuki M, Itakura H, Munakata A, Kinoshita K. Clinical investigation of renal pelvis and ureteral cancer with special reference to adjuvant chemotherapy. Nippon Hinyokika Gakkai Zasshi 1995;86:1375-82
12. Hall MC, Womack S, Sagalowsky Al, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594-601
13. Ozsahin M, Zouhair A, Villa S, Storme G, Chauvet B, Taussky D, et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre rare cancer network study. Ent J Cancer 1999;35:738-43
14. Sobin LH, Witterkind C. TNM classification of malignant tumors. 1st ed. New York: Wiley-Liss; 1997;183-6
15. Park S, Hong B, Kim Y, Kim CS, Ahn H. Prognostic factors for survival in the transitional cell carcinoma of the upper urinary tract. Korean J Urol 2003;44:1087-92
16. Jeong IG, Kwak C, Jeong H, Lee ES, Lee CW, Lee SE. Carcinoma of the upper urinary tract: clinical analysis on patients during recent 10 years. Korean J Urol 2003;44:22-7
17. Kim KH, Park JS, Kim CI, Lee KS. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Korean J Urol 2005;46:229-33
18. Miyake H, Hara I, Arakawa S, Kamidono S. A clinicopathological study of bladder cancer associated with upper urinary tract cancer. BJU Int 2000;85:37-41
19. Roupret M, Azzouzi AR, Cussenot O. Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int 2005;96:489-92
20. Vaish M, Mandhani A, Mittal RD, Mittal B. Microsatellite instability as prognostic marker in bladder tumors: a clinical significance. BMC Urol 2005;5:2
21. Roupret M, Coulet F, Azzouzi AR, Fromont G, Cussenot O. Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma. BJU Int 2005;96: 149-51
22. Roupret M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, et al. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 2005;65:1233-7
23. Amira N, Rivet J, Soliman H, Cancel-Tassin G, Le Duc A, Janin A, et al. Microsatellite instability in urothelial carcinoma of the upper urinary tract. J Urol 2003;170:1151-4
24. Jiricny J, Nystrom-Lahti M. Mismatch repair defects in cancer. Curr Opin Genet Dev 2000;10:157-61
25. Muller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002;20:102-9
26. Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, et al. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. J Clin Oncol 2005;23:5635-43
27. Myong NH. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with expressions of p53 and Ki-67 proteins. J Korean Med Sci 2003;18:494-500